5 Best No-Fee DRIP Stocks to Buy Now

Page 1 of 5

In this article, we will be taking a look at the 5 best no-fee DRIP stocks to buy now. To read our detailed analysis of dividend investing, you can go directly to see the 10 Best No-Fee DRIP Stocks to Buy Now.

5. Johnson & Johnson (NYSE: JNJ)

Number of Hedge Fund Holders: 88
Dividend Yield: 2.38%

Johnson & Johnson (NYSE: JNJ) sells a wide variety of healthcare products under its Johnson’s, Aveeno, Listerine, Clean & Clear, and other brands. The company ranks 5th on our list of the best no-fee DRIP stocks to buy now. It operates through its Consumer Health, Pharmaceutical, and Medical Devices segments.

As of this August, Morgan Stanley’s Matthew Harrison holds an Overweight rating and a $187 price target on shares of Johnson & Johnson (NYSE: JNJ).

In the second quarter of 2021, Johnson & Johnson (NYSE: JNJ) had an EPS of $2.48, beating estimates by $0.20. The company’s revenue was $23.31 billion, up 27.14% year over year and beating estimates by $802.29 million. Johnson & Johnson (NYSE: JNJ) has gained 11.84% in the past 6 months and 14.66% year to date.

By the end of the second quarter of 2021, 88 hedge funds out of the 873 tracked by Insider Monkey held stakes in Johnson & Johnson (NYSE: JNJ) worth roughly $7.1 billion. This is compared to 81 hedge funds in the previous quarter with a total stake value of approximately $6.9 billion.

Distillate Capital, an investment management firm,  mentioned Johnson & Johnson (NYSE: JNJ) in its second-quarter 2021 investor letter. Here’s what they said:

“The largest additions in the rebalance, Johnson & Johnson was around 50 and 40 basis points incrementally. J&J underperformed in the quarter while its normalized free cash flows held steady and so its position size was topped off to match the stable cash flows.”

Page 1 of 5